Cas:93752-20-6 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione manufacturer & supplier

Chemical Name:6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione

CAS.NO:93752-20-6

Synonyms:6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione

Molecular Formula:C₆H₄BrN₃S

Molecular Weight:230.08500

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:76.56000

Exact Mass:228.93100

LogP:2.38300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione Use and application,6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione technical grade,usp/ep/jp grade.

Related News: It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione manufacturer It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione supplier Both were in Siberia, and both are Chinese nationals who had recently traveled to China. 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione vendor The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. 6-bromo-1,3-dihydroimidazo[4,5-b]pyridine-2-thione factory The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.